Journal Club: Real-World Adherence and Persistence to Direct Oral Anticoagulants in Patients With Atrial Fibrillation

Mar 28, 2023 | Antithrombotics

1b) This is the third in a series; you can still earn 🆓CE/#CMEcredit for the first two tweetorials at https://t.co/mHOQVw4mlC and https://t.co/orYQvmXHu9. What a deal! pic.twitter.com/BEW3Vi0BCe— cardio-met (@cardiomet_CE) March 30, 2023 2a) Your co-hosts are Dr...

Journal Club: Trends in Use of OACs in Older Adults With Newly Diagnosed AFib, 2010-2020

Feb 28, 2023 | Antithrombotics

1b) This is a #journalclub review of an excellent article published in late 2022 in @JAMANetworkOpen 🔓 https://t.co/qoP1gddS4o. 👏to @darae_ko et al for such an important look at this topic that is only gaining in importance as the population ages.#CardioTwitter...

Anti-FXa DOAC Reversal in Patients with Bleeding After Major Trauma

Feb 19, 2023 | Antithrombotics

2) This program is supported by an educational grant from AstraZeneca & is intended for an audience of #healthcare providers. Statement of accreditation & faculty disclosures https://t.co/gvXca4G9Xm. Prior programs, still available for CE/#CME credit, at...

Journal Club: Underprescribing vs Underfilling in Oral Anticoagulation for SPAF

Jan 25, 2023 | Antithrombotics

1b) This is a #journalclub review of an excellent article published in late 2022 in J Manag Care Spec Pharm 🔓 https://t.co/nKfAvbrmNB.👏to @ihdezdelso et al for an insightful study on a topic only gaining in importance as the population ages....

Summary of Available Data on Specific DOAC Reversal and Nonspecific Factor Repletion in Patients with Anti-FXa-DOAC-Associated Hemorrhage

Jan 9, 2023 | Antithrombotics

2) This 🆓program is accredited for 0.5h CE/#CME for #physicians #physicianassociates #nurses #nurespractitioners #pharmacists and is supported by a grant from AstraZeneca. See statement of accreditation and faculty disclosures at https://t.co/gvXca4G9Xm.—...

Anti-FXa-DOAC-Associated GI Hemorrhage: Which Patients Should Be Reversed?

Dec 22, 2022 | Antithrombotics

2) I am Deborah Siegal MD MSc FRCOC @DebSiegal, a #hematologist @OttawaHospital, Tier 2 Canada Research Chair in Anticoagulant Management of Cardiovascular Disease, Associate Professor/Associate Scientist @uottawa pic.twitter.com/by15AJU9NP— cardio-met (@cardiomet_CE)...
« Older Entries

Accredited by:

In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Learn More at AcademicCME.com

  • Menu:
  • Home
  • Faculty
  • Disclosures